How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...

Disclaimer: When you purchase through links on our site, we may earn an affiliate commission. It's time to learn everything you need to know about HBO Max, one of the most popular streaming services ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Max is officially back to being HBO Max. Even though the name has changed (returned?), the library is still full of great films and shows to watch. HBO Max is home to some incredibly high-quality ...

The past few years have been a confusing time for HBO Max, and more importantly, anyone who wants to subscribe to it. From being called HBO Max back in 2020 to going with Max a few years later and ...

This article is updated frequently as titles leave and enter HBO Max. *New additions are indicated with an asterisk. You’ll find our selections organized into five genre categories — drama, action, ...

New HBO Max movies and shows drop on a regular basis, and the platform’s December 2025 schedule is gifting you top titles all month long, with brand new premieres of original movies and shows like ...